首页> 外国专利> MMP1 GENE TRANSCRIPTION PRODUCT AS PROGNOSTIC MARKER FOR OVARIAN CANCER AND TEST METHOD

MMP1 GENE TRANSCRIPTION PRODUCT AS PROGNOSTIC MARKER FOR OVARIAN CANCER AND TEST METHOD

机译:MMP1基因转录产物作为卵巢癌的预后标记和测试方法

摘要

PROBLEM TO BE SOLVED: To provide a prognostic marker and kit for ovarian cancer and a method for prognostic prediction.SOLUTION: According to the present invention, there are provided a prognostic marker and kit for ovarian cancer, comprising a transcript of matrix metalloprotease (MMP) 1 gene. There is also provided a method for prognostic prediction of ovarian cancer using the marker or the kit. The method comprises detecting expression level of matrix metalloproteinase (MMP) 1 gene in a biological sample collected from a subject by detecting an ovarian cancer prognostic marker consisting of a transcript of matrix metalloprotease (MMP) 1 gene to obtain a detection value of the ovarian cancer prognostic marker.SELECTED DRAWING: Figure 1
机译:解决的问题:提供卵巢癌的预后标志物和试剂盒以及预后预测的方法。解决方案:根据本发明,提供了一种卵巢癌的预后标志物和试剂盒,其包括基质金属蛋白酶(MMP)的转录本)1个基因。还提供了一种使用标志物或试剂盒预测卵巢癌的方法。该方法包括通过检测由基质金属蛋白酶(MMP)1基因的转录物组成的卵巢癌预后标志物来检测从受试者收集的生物学样品中的基质金属蛋白酶(MMP)1基因的表达水平,以获得卵巢癌的检测值。预后标记图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号